trending Market Intelligence /marketintelligence/en/news-insights/trending/Qsjm0MqTt_q6feMQCDLSzw2 content esgSubNav
In This List

Shanghai Fosun completes stake acquisition in Indian generic maker

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Shanghai Fosun completes stake acquisition in Indian generic maker

Shanghai Fosun Pharmaceutical (Group) Co. Ltd. completed its acquisition of a 74% stake in Indian generic maker Gland Pharma Ltd.

Following completion of the $1.1 billion deal, Gland Pharma is now an indirect non-wholly owned subsidiary of Shanghai Fosun.